$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

인지기능 개선을 위한 식품유래 생리활성소재에 대한 체계적 문헌고찰
Bioactive compounds in food for age-associated cognitive decline: A systematic review 원문보기

한국식품과학회지 = Korean journal of food science and technology, v.53 no.3, 2021년, pp.278 - 289  

강은영 (한양대학교 생활과학대학 식품영양학과) ,  최봉교 (한양대학교 생활과학대학 식품영양학과) ,  김현경 (한양대학교 생활과학대학 식품영양학과) ,  고광웅 (한양대학교 생활과학대학 식품영양학과)

초록
AI-Helper 아이콘AI-Helper

본 연구는 인지기능 개선에 도움이 되는 천연기능성소재를 선발하기 위해 체계적 문헌고찰을 실시하였다. 2020년 10월 06일 기준 문헌검색을 통해 16,184건을 수집하였고 선택 및 배제 기준에 따라 총 27건의 문헌을 선별하였다. 27건 중 ω-3 지방산 관련 논문 12건, 비타민 B군 관련 논문 8건, 비타민 D와 E 관련 논문 각각 1건이었으며, 안세린/카르노신, 베테인, 카페인, 크로뮴, 피소스티그민 관련 논문이 각각 1건이었다. 각 문헌의 비뚤림 위험 평가를 진행한 결과 ω-3 지방산 관련 논문 2건, 비타민 B군 관련 논문 1건, 베테인, 카페인, 피소스티그민 관련 논문의 비뚤림 위험이 '높음'으로 평가되었고, 비뚤림 위험이 높다고 평가된 6건의 논문들을 제외하고 근거수준평가 및 결과분석을 시행하였다. ω-3 지방산 관련 논문은 6-24개월동안 DHA 0.48-2.2 g, EPA 203-720 mg의 용량을 함께 또는 따로 중재하여 총 1,031명의 대상자 중 437명의 유의적인 효과를 확인하였다. 경도인지장애 환자를 대상으로 진행된 ω-3 지방산 논문에서는 인지기능영역(공간력, 기억력, 회상력, 언어력)과 인지기능 관련 바이오마커(Aβ-42, APP mRNA)를 개선시키는 등 치매개선에 긍정적인 효과를 나타냈다. 그러나 치매 환자를 대상으로 한 ω-3 지방산 연구에서는 인지기능평가에 대한 개선효과를 확인하기 어려웠다. 비타민 B 관련 논문은 6 또는 24개월 동안 엽산 400-800 ㎍, 비타민 B12 25-500 ㎍, 비타민 B6 20 mg의 용량을 함께 또는 따로 중재하여 총 1,180명의 대상자 중 530명에서 유의적인 효과를 확인하였다. 비타민 B군의 섭취는 치매 위험성과 관련된 혈중 호모시스테인 농도를 감소시켰으며, 혈중 ω-3 지방산의 농도와 높은 상관관계를 나타내는 것을 확인할 수 있었다. 그 외에 비타민 D와 E는 인지기능관련 바이오마커(Aβ-42, APP mRNA, PS1 mRNA)를 감소시키고 인지기능평가(WAIS-RC, ADAS-cog) 개선효과를 나타냈으며 안세린/카르노신은 치매척도검사를 개선하였고 크로뮴 섭취는 기억력 부분의 인지기능영역을 유의적으로 개선하였다. 그러나 ω-3 지방산과 비타민 B를 제외한 연구들은 선별된 문헌의 개수가 제한적이며, 개선 효과를 판단할 근거가 부족하였다. 중재 기간 및 용량에 따라 결과를 종합하면, ω-3 지방산은 6개월 이상 DHA 0.48-2.2 g, EPA 203-720 mg의 용량을 복합 또는 DHA 단독으로 중재했을 경우 인지기능 개선 효과를 확인할 수 있었으며, 엽산 400-800 ㎍, 비타민 B12 25-500 ㎍, 비타민 B6 20 mg의 용량을 복합 또는 엽산을 단독으로 6개월 이상 중재할 경우 혈중 호모시스테인 농도 감소와 인지능력개선을 확인할 수 있었다.

Abstract AI-Helper 아이콘AI-Helper

The rapid aging of society has led to a surge in cognitive dysfunction in the elderly. As there is limited evidence for the development of dementia in medicine, a shift in focus on prevention strategies using bioactive compounds in food is required. This systematic review evaluated the effects of va...

주제어

표/그림 (6)

참고문헌 (70)

  1. Aisen PS, Schneider LS, Sano M, Diaz-Arrastia R, Van Dyck CH, Weiner MF, Bottiglieri T, Jin S, Stokes KT, Thomas RG, Thal, LJ. High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. Jama 300: 1774-1783 (2008) 

  2. Akhtar A, Dhaliwal J, Saroj P, Uniyal A, Bishnoi M, Sah SP. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Inflammopharmacology 28: 385-400 (2020) 

  3. Ali MM, Ghouri RG, Ans AH, Akbar A, Toheed A. Recommendations for anti-inflammatory treatments in Alzheimer's disease: a comprehensive review of the literature. Cureus 11: e4620 (2019) 

  4. Artero S, Tierney MC, Touchon J, Ritchie K. Prediction of transition from cognitive impairment to senile dementia: a prospective, longitudinal study. Acta Psychiatr. Scand. 107: 390-393 (2003) 

  5. Bo Y, Zhang X, Wang Y, You J, Cui H, Zhu Y, Pang W, Liu W, Jiang Y, Lu Q. The n-3 polyunsaturated fatty acids supplementation improved the cognitive function in the Chinese elderly with mild cognitive impairment: a double-blind randomized controlled trial. Nutrients 9: 54 (2017) 

  6. Buell JS, Dawson-Hughes B, Scott TM, Weiner DE, Dallal GE, Qui WQ, Bergethon P, Rosenberg IH, Folstein MF, Patz S, Bhadelia RA, Tucker KL. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 74: 18-26 (2010) 

  7. Cederholm T. Fish consumption and omega-3 fatty acid supplementation for prevention or treatment of cognitive decline, dementia, or Alzheimer's disease in older adults-any news? Curr. Opin. Clin. Nutr. Metab. Care 20: 104-109 (2017) 

  8. de Jager CA, Oulhaj A, Jacoby R, Refsum H, Smith AD. Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial. Int. J. Geriatr. Psychiatry 27: 592-600 (2012) 

  9. DeKosky ST, Williamson JD, Fitzpatrick AL, Kronmal RA, Ives DG, Saxton JA, Lopez OL, Burke G, Carlson MC, Fried LP, Kuller LH, Robbins JA, Tracy RP, Woolard NF, Dunn L, Snitz BE, Nahin RL, Furberg CD, Ginkgo Evaluation of Memory (GEM) Study Investigators. Ginkgo biloba for prevention of dementia: a randomized controlled trial. Jama 300: 2253-2262 (2008) 

  10. Dickerson BC, Goncharova I, Sullivan MP, Forchetti C, Wilson RS, Bennett DA, Beckett LA, deToledo-Morrell L. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol. Aging 22: 747-754 (2001) 

  11. Ding Q, Tanigawa K, Kaneko J, Totsuka M, Katakura Y, Imabayashi E, Matsuda H, Hisatsune T. Anserine/carnosine supplementation preserves blood flow in the prefrontal brain of elderly people carrying APOE ε4. Aging Dis. 9: 334 (2018) 

  12. Dyall SC, Michael-Titus AT. Neurological benefits of omega-3 fatty acids. Neuromolecular Med. 10: 219-235 (2008) 

  13. Dysken MW, Sano M, Asthana S, Vertrees JE, Pallaki M, Llorente M, Love S, Schellenberg GD, McCarten JR, Malphurs J, et al. Effect of vitamin E and memantine on functional decline in Alzheimer's disease: the TEAM-AD VA cooperative randomized trial. Jama 311: 33-44 (2014) 

  14. Eckert GP, Lipka U, Muller WE. Omega-3 fatty acids in neurodegenerative disease: focus on mitochondria. Prostaglandins, Leukot. Essent. Fatty Acids 88: 105-114 (2013) 

  15. Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, FaxenIrving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma fatty acid profiles in relation to cognition and gender in Alzheimer's disease patients during oral omega-3 fatty acid supplementation: The OmegAD study. J. Alzheimers Dis. 48: 805-812 (2015) 

  16. Feart C, Letenneur L, Helmer C, Samieri C, Schalch W, Etheve S, Delcourt C, Dartigues JF, Barberger-Gateau P. Plasma carotenoids are inversely associated with dementia risk in an elderly French cohort. J. Gerontol. A Biol. Sci. Med. Sci. 71: 683-688 (2016) 

  17. Freund-Levi Y, Eriksdotter-Jonhagen M, Cederholm T, Basun H, Faxen-Irving G, Garlind A, Vedin I, Vessby B, Wahlund LO, Palmblad J. ω-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63: 1402-1408 (2006) 

  18. Freund-Levi Y, Basun H, Cederholm T, Faxen-Irving G, Garlind A, Grut M, Vedin I, Palmblad J, Wahlund LO, Eriksdotter-Jonhagen M. Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms. Int. J. Geriatr. Psychiatry 23: 161-169 (2008) 

  19. Freund-Levi Y, Vedin I, Hjorth E, Basun H, Faxen Irving G, Schultzberg M, Eriksdotter M, Palmblad J, Vessby B, Wahlund LO, Cederholm T, Basu S. Effects of supplementation with omega-3 fatty acids on oxidative stress and inflammation in patients with Alzheimer's disease: the OmegAD study. J. Alzheimer's Dis. 42: 823-831 (2014) 

  20. Garcion E, Wion-Barbot N, Montero-Menei CN, Berger F, Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 13: 100-105 (2002) 

  21. Gauthier S, Reisberg B, Zaudig M, Petersen RC, Ritchie K, Broich K, Belleville S, Brodaty H, Bennett D, Chertkow H, Cummings JL, de Leon M, Feldman H, Ganguli M, Hampel H, Scheltens P, Tierney MC, Whitehouse P, Winblad B. Mild cognitive impairment. The lancet 367: 1262-1270 (2006) 

  22. Green R, Allen LH, Bjorke-Monsen AL, Brito A, Gueant JL, Miller JW, Molloy AM, Nexo E, Stabler S, Toh BH, Ueland PM, Yajnik C. Vitamin B 12 deficiency. Nat. Rev. Dis. Primers 3: 1-20 (2017) 

  23. Gugliandolo A, Bramanti P, Mazzoz E. Role of vitamin E in the treatment of Alzheimer's disease: Evidence from animal models. Int. J. Mol. Sci. 18:2504 (2017) 

  24. Haller S, Montandon ML, Rodriguez C, Moser D, Toma S, Hofmeister J, Sinanaj I, Lovblad KO, Giannakopoulos P. Acute caffeine administration effect on brain activation patterns in mild cognitive impairment. J. Alzheimers Dis. 41: 101-112 (2014) 

  25. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams K, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41: 1088-1093 (2009) 

  26. Hashimoto M, Kato S, Tanabe Y, Katakura M, Mamun AA, Ohno M, Hossain S, Onoda K, Yamaguchi S, Shido O. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr. Gerontol. Int. 17: 330-337 (2017) 

  27. Henderson VW. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause. J. Steroid Biochem. Mol. Biol. 142: 99-106 (2014) 

  28. Hopperton KE, Trepanier MO, Giuliano V, Bazinet RP. Brain omega-3 polyunsaturated fatty acids modulate microglia cell number and morphology in response to intracerebroventricular amyloid-β 1-40 in mice. J. Neuroinflammation 13: 1-18 (2016) 

  29. Isaac MGEKN, Quinn R, Tabet N. Vitamin E for Alzheimer's disease and mild cognitive impairment. Cochrane Database Syst. Rev. 3 (2008) 

  30. Jerneren F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am. J. Clin. Nutr. 102: 215-221 (2015) 

  31. Jia J, Hu J, Huo X, Miao R, Zhang Y, Ma F. Effects of vitamin D supplementation on cognitive function and blood Aβ-related bio-markers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry Res. 90: 1347-1352 (2019) 

  32. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr. Opin. Clin. Nutr. Metab. Care 10: 12-19 (2007) 

  33. Karimi M, Vedin I, Freund Levi Y, Basun H, Faxen Irving G, Eriksdotter M, Wahlund LO, Schultzberg M, Hjorth E, Cederholm T, Palmblad J. DHA-rich n-3 fatty acid supplementation decreases DNA methylation in blood leukocytes: the OmegAD study. Am. J. Clin. Nutr. 106: 1157-1165 (2017) 

  34. Killin LO, Starr JM, Shiue IJ, Russ TC. Environmental risk factors for dementia: a systematic review. BMC Geriatr. 16: 1-28 (2016) 

  35. Krikorian R, Eliassen JC, Boespflug EL, Nash TA, Shidler MD. Improved cognitive-cerebral function in older adults with chromium supplementation. Nutr. Neurosci. 13: 116-122 (2010) 

  36. Kryscio RJ, Abner EL, Caban-Holt A, Lovell, M, Goodman P, Darke AK, Yee M, Crowley J, Schmitt FA. Association of antioxidant supplement use and dementia in the prevention of Alzheimer's disease by vitamin E and selenium trial (PREADViSE). JAMA Neurol. 74: 567-573 (2017) 

  37. Lambert JC, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41: 1094-1099 (2009) 

  38. Lee DW, Seong SJ. Korean national dementia plans: from 1st to 3rd. J. Korean Med. Assoc. 61: 298-303 (2018) 

  39. Lee LK, Shahar S, Chin AV, Yusoff NAM. Docosahexaenoic acidconcentrated fish oil supplementation in subjects with mild cognitive impairment (MCI): a 12-month randomised, double-blind, placebo-controlled trial. Psychopharmacology 225: 605-612 (2013) 

  40. Ma F, Li Q, Zhou X, Zhao J, Song A, Li W, Liu H, Xu W, Huang G. Effects of folic acid supplementation on cognitive function and Aβ-related biomarkers in mild cognitive impairment: a randomized controlled trial. Eur. J. Nutr. 58: 345-356 (2019a) 

  41. Ma F, Zhou X, Li Q, Zhao J, Song A, An P, Du Y, Xu W, Huang G. Effects of folic acid and vitamin B 12 , alone and in combination on cognitive function and inflammatory factors in the elderly with mild cognitive impairment: A single-blind experimental design. Curr. Alzheimer Res. 16: 622-632 (2019b) 

  42. Macready AL, Kennedy OB, Ellis JA, Williams CM, Spencer JP, Butler LT. Flavonoids and cognitive function: a review of human randomized controlled trial studies and recommendations for future studies. Genes Nutr. 4: 227-242 (2009) 

  43. Masuoka N, Yoshimine C, Hori M, Tanaka M, Asada T, Abe K, Hisatsune T. Effects of anserine/carnosine supplementation on mild cognitive impairment with APOE ε4. Nutrients 11: 1626 (2019) 

  44. Moll R, Davis B. Iron, vitamin B 12 and folate. Medicine 45: 198-203 (2017) 

  45. Morello M, Landel V, Lacassagne E, Baranger K, Annweiler C, Feron F, Millet P. Vitamin D improves neurogenesis and cognition in a mouse model of Alzheimer's disease. Mol. Neurobiol. 55: 6463-6479 (2018) 

  46. Mucke L. Alzheimer's disease. Nature 461: 895-897 (2009) 

  47. National Institutes of Health. How is Alzheimer's disease treated? Available from: https://www.nia.nih.gov/health/how-alzheimersdisease-treated. Accessed Jan. 25, 2021 

  48. National Institutes of Health. What is mild cognitive impairment? Available from: https://www.nia.nih.gov/health/what-mild-cognitive-impairment. Accessed Jan. 25, 2021 

  49. Oulhaj A, Jerneren F, Refsum H, Smith AD, de Jager CA. Omega-3 fatty acid status enhances the prevention of cognitive decline by B vitamins in mild cognitive impairment. J. Alzheimers Dis. 50: 547-557 (2016) 

  50. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 352: 2379-2388 (2005) 

  51. Petersen RC. Mild cognitive impairment. N. Engl. J. Med. 364: 2227-2234 (2011) 

  52. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. Jama 304: 1903-1911 (2010) 

  53. Refsum H, Smith AD, Ueland PM, Nexo E, Clarke R, McPartlin J, Johnston C, Engbaek F, Schneede J, McPartlin C, Scott JM. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem. 50: 3-32 (2004) 

  54. Riggs KM, Spiro 3rd A, Tucker K, Rush D. Relations of vitamin B 12 , vitamin B 6 , folate, and homocysteine to cognitive performance in the Normative Aging Study. Am. J. Clin. Nutr. 63: 306-314 (1996) 

  55. Rogaeva E, Meng Y, Lee JH, Gu Y, Kawarai T, Zou F, Katayama T, Baldwin CT, Cheng R, Hasegawa H, et al. The neuronal sortilinrelated receptor SORL1 is genetically associated with Alzheimer disease. Nat. Genet. 39: 168-177 (2007) 

  56. Sano M, Ernesto C, Thomas RG, Klauber MR, Schafer K, Grundman M, Woodbury P, Growdon J, Cotman CW, Pfeiffer E, Schneider LS, Thal LJ. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N. Engl. J. Med. 336: 1216-1222 (1997) 

  57. Scholey AB, Camfield DA, Hughes ME, Woods W, Stough CKK, White DJ, Gondalia SV, Frederiksen PD. A randomized controlled trial investigating the neurocognitive effects of Lacprodan ® PL-20, a phospholipid-rich milk protein concentrate, in elderly participants with age-associated memory impairment: The Phospholipid Intervention for Cognitive Ageing Reversal (PLICAR): study protocol for a randomized controlled trial. Trials 14: 1-15 (2013) 

  58. Schultz BG, Patten DK, Berlau DJ. The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms. Transl. Neurodegener. 7: 1-11 (2018) 

  59. Smith AD, Smith SM, de Jager CA, Whitbread P, Johnston C, Agacinski G, Oulhaj A, Bradley KM, Jacoby R, Refsum H. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PloS one 5: e12244 (2010) 

  60. Statistics Korea. 2020 Elderly statistics. Available from: http://kostat.go.kr/portal/korea/kor_nw/1/1/index.board?bmoderead&aSeq385322. Accessed Jan. 25, 2021 

  61. Sun J, Wen S, Zhou J, Ding S. Association between malnutrition and hyperhomocysteine in Alzheimer's disease patients and diet intervention of betaine. J. Clin. Lab. Anal. 31: e22090 (2017) 

  62. Szczesniak D, Budzen S, Kopec W, Rymaszewska J. Anserine and carnosine supplementation in the elderly: Effects on cognitive functioning and physical capacity. Arch. Gerontol. Geriat. 59: 485-490 (2014) 

  63. Thal LJ, Ferguson JM, Mintzer JE, Raskin A, Targum SD. A 24- week randomized trial of controlled-release physostigmine in patients with Alzheimer's disease. Neurology 52: 1146-1146 (1999) 

  64. van Uffelen JG, Chinapaw MJ, van Mechelen W, Hopman-Rock M. Walking or vitamin B for cognition in older adults with mild cognitive impairment? A randomised controlled trial. Br. J. Sports Med. 42: 344-351 (2008) 

  65. Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Faxen Irving G, Eriksdotter-Jonhagen M, Wahlund LO, Dahlman I, Palmblad J. Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PloS one 7: e35425 (2012) 

  66. Wilson MP, Plecko B, Mills PB, Clayton PT. Disorders affecting vitamin B 6 metabolism. J. Inherit. Metab. Dis. 42: 629-646 (2019) 

  67. World Health Organization. Dementia. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia. Accessed Jan. 25, 2021 

  68. Yokota T, lgarashi K, Uchihara T, Jishage KI, Tomita H, Inaba A, Li Y, Arita M, Suzuki H, Mizusawa H, Arai H. Delayed-onset ataxia in mice lacking α-tocopherol transfer protein: model for neuronal degeneration caused by chromic oxidative stress. Proc. Natl. Acad. Sci. 98: 15185-15190 (2001) 

  69. Zhang YP, Lou Y, Hu J, Miao R, Ma F. DHA supplementation improves cognitive function via enhancing Aβ-mediated autophagy in Chinese elderly with mild cognitive impairment: a randomised placebo-controlled trial. J. Neurol. Neurosurg. Psychiatry Res. 89: 382-388 (2018) 

  70. Zhang YP, Miao R, Li Q, Wu T, Ma F. Effects of DHA supplementation on hippocampal volume and cognitive function in older adults with mild cognitive impairment: A 12-month randomized, double-blind, placebo-controlled trial. J. Alzheimers Dis. 55: 497-507 (2017) 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

BRONZE

출판사/학술단체 등이 한시적으로 특별한 프로모션 또는 일정기간 경과 후 접근을 허용하여, 출판사/학술단체 등의 사이트에서 이용 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로